Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 4.
Article
Le Gall, L;
Sidlauskaite, E;
Mariot, V;
Dumonceaux, J;
(2020)
Therapeutic Strategies Targeting DUX4 in FSHD.
Journal of Clinical Medicine
, 9
(9)
, Article 2886. 10.3390/jcm9092886.
|
 |
|
Mariot, V;
Joubert, R;
Le Gall, L;
Sidlauskaite, E;
Hourde, C;
Duddy, W;
Voit, T;
... Dumonceaux, J; + view all
(2021)
RIPK3-mediated cell death is involved in DUX4-mediated toxicity in facioscapulohumeral dystrophy.
Journal of Cachexia, Sarcopenia and Muscle
10.1002/jcsm.12813.
(In press).
|
|
|
Sidlauskaite, E;
Gibson, JW;
Megson, IL;
Whitfield, PD;
Tovmasyan, A;
Batinic-Haberle, I;
Murphy, MP;
... Cobley, JN; + view all
(2018)
Mitochondrial ROS cause motor deficits induced by synaptic inactivity: Implications for synapse pruning.
Redox Biology
, 16
pp. 344-351.
10.1016/j.redox.2018.03.012.
|
|
|
Sidlauskaite, E;
Le Gall, L;
Mariot, V;
Dumonceaux, J;
(2020)
DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation.
Journal of Personalized Medicine
, 10
(3)
, Article 73. 10.3390/jpm10030073.
|
|
